BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30856024)

  • 1. Diagnostic utility of bronchoscopy in adults with acute myeloid leukemia and other high-grade myeloid neoplasms.
    Buckley SA; Mark NM; Othus M; Estey EH; Patel K; Walter RB
    Leuk Lymphoma; 2019 Sep; 60(9):2304-2307. PubMed ID: 30856024
    [No Abstract]   [Full Text] [Related]  

  • 2. [Progressive multifocal leukoencephalopathy in a patient with acute myeloid leukaemia after allogeneic hematopoietic-cell transplantation].
    Fernández-Ruiz M; de la Serna J; Ruiz J; López-Medrano F
    Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):636-7. PubMed ID: 21696864
    [No Abstract]   [Full Text] [Related]  

  • 3. Postallogeneic hematopoietic stem cell transplantation relapse of acute myeloid leukemia presenting with salivary gland myelosarcoma.
    Lai YH; Chang CS; Liu YC; Liu TC
    Ann Hematol; 2010 Jun; 89(6):631-3. PubMed ID: 19816683
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycophenolate mofetil is associated with inferior overall survival in cytomegalovirus-seropositive patients with acute myeloid leukemia undergoing hematopoietic cell transplantation.
    Saliba RM; Lee SJ; Carpenter PA; Hill GR; Lee CJ; Alousi A; Daher M; Chen G; Champlin RE; Rezvani K; Shpall EJ; Mehta RS
    Haematologica; 2024 Jul; 109(7):2321-2325. PubMed ID: 38426274
    [No Abstract]   [Full Text] [Related]  

  • 5. Invasive fungal infections in patients with acute myeloid leukemia and in those submitted to allogeneic hemopoietic stem cell transplant: who is at highest risk?
    Caira M; Girmenia C; Fadda RM; Mitra ME; Picardi M; Van Lint MT; Nosari A; Candoni A; Bonini A; Mattei D; de Waure C; Fianchi L; Valentini CG; Aversa F; Leone G; Pagano L
    Eur J Haematol; 2008 Sep; 81(3):242-3. PubMed ID: 18485113
    [No Abstract]   [Full Text] [Related]  

  • 6. Contribution of non-infectious transplantation-related complications to the outcome of hematopoietic stem cell transplantation in patients with acute myeloid leukemia: a single institute analysis.
    Watamoto K; Kohno A; Adachi Y; Umemura K; Yamaguchi Y; Tatekawa S; Ozeki K; Morishita Y
    Int J Hematol; 2015 Jan; 101(1):83-91. PubMed ID: 25380682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnostic bronchoscopy in solid-organ and hematopoietic stem cell transplantation.
    Harris B; Lowy FD; Stover DE; Arcasoy SM
    Ann Am Thorac Soc; 2013 Feb; 10(1):39-49. PubMed ID: 23509331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical outcome of allogeneic hematopoietic stem cell transplantation with FLAG sequential busulfan/cyclophosphamide conditioning regimen for refractory/relapsed acute myeloid leukemia].
    Liu W; Li Y; Qiu ZX; Yin Y; Sun YH; Xu WL; Wang Q; Liang ZY; Dong YJ; Wang LH; Cen QN; Wang MJ; Wang WS; Ou JP; Ren HY
    Zhonghua Nei Ke Za Zhi; 2018 Aug; 57(8):576-581. PubMed ID: 30060329
    [No Abstract]   [Full Text] [Related]  

  • 9. Neck infection after allogenic hematopoietic progenitors transplantation.
    Mensa J; Dueñas Gutiérrez C; Cardozo C; Rodríguez Fernández L; Kestler M; Muñoz P; Bouza E
    Rev Esp Quimioter; 2020 Apr; 33(2):130-136. PubMed ID: 32056419
    [No Abstract]   [Full Text] [Related]  

  • 10. Oral manifestations in stem cell transplantation for acute myeloid leukemia.
    Mester A; Irimie A; Oprita L; Dima D; Petrushev B; Lucaciu O; Campian RS; Tanase A
    Med Hypotheses; 2018 Dec; 121():191-194. PubMed ID: 30396479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.
    Gürman G; Arat M; Ilhan O; Konuk N; Beksaç M; Celebi H; Ozcan M; Arslan O; Ustün C; Akan H; Uysal A; Koç H
    Cytotherapy; 2001; 3(4):253-60. PubMed ID: 12171713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Follow-Up and Impact of Comorbidity before Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Relapsed or Refractory Acute Myeloid Leukemia-Lessons Learned from the Prospective BRIDGE Trial.
    Middeke JM; Herbst R; Parmentier S; Bug G; Hänel M; Stuhler G; Schäfer-Eckart K; Rösler W; Klein S; Bethge W; Bitz U; Büttner B; Knoth H; Alakel N; Schaich M; Morgner A; Kramer M; Sockel K; von Bonin M; Stölzel F; Platzbecker U; Röllig C; Thiede C; Ehninger G; Bornhäuser M; Schetelig J
    Biol Blood Marrow Transplant; 2017 Sep; 23(9):1491-1497. PubMed ID: 28527985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Different Conditioning Regimens of Haploidentical Hematopoietic Stem Cell Transplant in Patients With Acute Myeloid Leukemia.
    Jiang Y; Fang X; Sui X; Liu X; Li Y; Wang X; Xu H; Zhang L; Wang X
    Exp Clin Transplant; 2018 Dec; 16(6):736-744. PubMed ID: 29790457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion-related acute lung injury (TRALI) following allogeneic stem cell transplant for acute myeloid leukemia.
    Ganguly S; Carrum G; Nizzi F; Heslop HE; Popat U
    Am J Hematol; 2004 Jan; 75(1):48-51. PubMed ID: 14695632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of flexible bronchoscopy in the evaluation of pulmonary infiltrates in the hematopoietic stem cell transplant population -- a single center fourteen year experience.
    Gilbert CR; Lerner A; Baram M; Awsare BK
    Arch Bronconeumol; 2013 May; 49(5):189-95. PubMed ID: 23455477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mismatched unrelated hematopoietic stem cell transplantation with post-transplant cyclophosphamide for high-risk acute myeloid leukemia.
    Lindner S; Berg T; Riemann J; Ajib S; Jedlickova Z; Gueller S; Lang F; Martin H; Serve H; Bacigalupo A; Bug G
    Ann Hematol; 2016 May; 95(6):1023-5. PubMed ID: 27056199
    [No Abstract]   [Full Text] [Related]  

  • 17. Chemotherapy followed by modified donor lymphocyte infusion as a treatment for relapsed acute leukemia after haploidentical hematopoietic stem cell transplantation without in vitro T-cell depletion: superior outcomes compared with chemotherapy alone and an analysis of prognostic factors.
    Yan CH; Wang JZ; Liu DH; Xu LP; Chen H; Liu KY; Huang XJ
    Eur J Haematol; 2013 Oct; 91(4):304-14. PubMed ID: 23837640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early tapering of immunosuppressive agents after HLA-matched donor transplantation can improve the survival of patients with advanced acute myeloid leukemia.
    Yang J; Cai Y; Jiang J; Wan L; Bai H; Zhu J; Li S; Wang C; Song X
    Ann Hematol; 2018 Mar; 97(3):497-507. PubMed ID: 29250743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of graft-versus-host disease after reduced-intensity conditioning allogeneic stem cell transplantation for acute myeloid leukemia: a report from the Acute Leukemia Working Party of the European group for blood and marrow transplantation.
    Baron F; Labopin M; Niederwieser D; Vigouroux S; Cornelissen JJ; Malm C; Vindelov LL; Blaise D; Janssen JJ; Petersen E; Socié G; Nagler A; Rocha V; Mohty M
    Leukemia; 2012 Dec; 26(12):2462-8. PubMed ID: 22699419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT.
    Baron F; Ruggeri A; Beohou E; Labopin M; Mohty M; Sanz J; Vigouroux S; Furst S; Bosi A; Chevallier P; Cornelissen JJ; Michallet M; Sierra J; Karakasis D; Savani BN; Gluckman E; Nagler A
    J Intern Med; 2018 Feb; 283(2):178-189. PubMed ID: 28977716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.